Company | Name | Exchange | Sector | Industry | Analyst Recommendation | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Kamada | NASDAQ | Healthcare | Pharmaceuticals | 1.5 | $452.18M | 28x | 0.24 | $7.83 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Corcept | NASDAQ | Healthcare | Pharmaceuticals | 1.5 | $7.69B | 54.7x | 0.94 | $73.53 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 31.4% Upside | Upgrade to Pro+ | |
Takeda Pharma ADR | NYSE | Healthcare | Pharmaceuticals | 1.5 | $437.76M | 31.7x | 2.05 | $13.74 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 18.2% Upside | Upgrade to Pro+ | |
Genfit | NASDAQ | Healthcare | Biotechnology & Medical Research | 1.5 | $191.73M | 8.2x | 0.05 | $3.84 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
The Ensign | NASDAQ | Healthcare | Healthcare Providers & Services | 1.5 | $7.24B | 24.1x | 0.61 | $127.12 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 30.4% Upside | Upgrade to Pro+ | |
Addus | NASDAQ | Healthcare | Healthcare Providers & Services | 1.5 | $2.03B | 25.6x | 1.16 | $113.22 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 24.4% Upside | Upgrade to Pro+ | |
Iradimed Co | NASDAQ | Healthcare | Healthcare Equipment & Supplies | 1.5 | $720.49M | 37.4x | 3.28 | $56.74 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 24.6% Upside | Upgrade to Pro+ | |
ICON PLC | NASDAQ | Healthcare | Biotechnology & Medical Research | 1.53 | $15.84B | 21.1x | 0.46 | $191.32 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 32.9% Upside | Upgrade to Pro+ | |
Alcon | NYSE | Healthcare | Healthcare Equipment & Supplies | 1.56 | $44.29B | 37.9x | 0.25 | $89.56 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 16.3% Upside | Upgrade to Pro+ | |
Insulet | NASDAQ | Healthcare | Healthcare Equipment & Supplies | 1.57 | $19.93B | 47.5x | 0.2 | $283.68 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 5.8% Upside | Upgrade to Pro+ | |
Ligand | NASDAQ | Healthcare | Pharmaceuticals | 1.57 | $2.30B | 48x | 0.31 | $122 | 1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 18.4% Upside | Upgrade to Pro+ | |
Merit | NASDAQ | Healthcare | Healthcare Equipment & Supplies | 1.6 | $6.23B | 51.7x | 2.71 | $106.41 | -2.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 10.7% Upside | Upgrade to Pro+ | |
Sensus Health | NASDAQ | Healthcare | Healthcare Equipment & Supplies | 1.6 | $92.21M | 13.8x | 0.01 | $5.71 | -2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Protagonist Therapeutics | NASDAQ | Healthcare | Biotechnology & Medical Research | 1.6 | $2.30B | 13.7x | 0.07 | $38.53 | 2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Neurocrine | NASDAQ | Healthcare | Biotechnology & Medical Research | 1.62 | $11.39B | 33.5x | 1.01 | $114.26 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 44.8% Upside | Upgrade to Pro+ | |
Thermo Fisher Scientific | NYSE | Healthcare | Healthcare Equipment & Supplies | 1.63 | $203.19B | 31.9x | 4.59 | $530.86 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 27.1% Upside | Upgrade to Pro+ | |
Tenet Healthcare | NYSE | Healthcare | Healthcare Providers & Services | 1.65 | $12.92B | 4.2x | 0.01 | $135.65 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 30.7% Upside | Upgrade to Pro+ | |
Jazz Pharma | NASDAQ | Healthcare | Pharmaceuticals | 1.65 | $8.16B | 18.3x | 0.04 | $134.96 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 33.8% Upside | Upgrade to Pro+ | |
Sarepta | NASDAQ | Healthcare | Biotechnology & Medical Research | 1.65 | $10.22B | 84.7x | 0.73 | $107.12 | 1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
IQVIA Holdings | NYSE | Healthcare | Biotechnology & Medical Research | 1.65 | $34.64B | 25.9x | 9.04 | $196.51 | 1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 29.4% Upside | Upgrade to Pro+ | |
Biomarin Pharma | NASDAQ | Healthcare | Pharmaceuticals | 1.65 | $12.47B | 38.3x | 0.32 | $65.61 | 1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 45.1% Upside | Upgrade to Pro+ | |
AstraZeneca ADR | NASDAQ | Healthcare | Pharmaceuticals | 1.67 | $227.92B | 32.5x | 1.79 | $73.81 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 17.8% Upside | Upgrade to Pro+ | |
Elevance Health | NYSE | Healthcare | Healthcare Providers & Services | 1.68 | $90.74B | 15.1x | 8.34 | $391.71 | 2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 25.5% Upside | Upgrade to Pro+ | |
Becton Dickinson | NYSE | Healthcare | Healthcare Equipment & Supplies | 1.71 | $65.30B | 38.1x | 0.91 | $227.56 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 21.4% Upside | Upgrade to Pro+ | |
Labcorp Holdings | NYSE | Healthcare | Healthcare Providers & Services | 1.74 | $20.64B | 27.8x | 0.32 | $247.82 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 9.6% Upside | Upgrade to Pro+ | |
Zoetis Inc | NYSE | Healthcare | Pharmaceuticals | 1.75 | $70.22B | 28.6x | 3.6 | $156.64 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 27.8% Upside | Upgrade to Pro+ | |
Eli Lilly | NYSE | Healthcare | Pharmaceuticals | 1.75 | $780.63B | 73.8x | 0.7 | $867.05 | 1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 15.7% Upside | Upgrade to Pro+ | |
TransMedics | NASDAQ | Healthcare | Healthcare Equipment & Supplies | 1.78 | $2.65B | 79.3x | 0.4 | $79.42 | 5.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 40.6% Upside | Upgrade to Pro+ | |
Abbott Labs | NYSE | Healthcare | Healthcare Equipment & Supplies | 1.78 | $229.21B | 17.2x | 0.13 | $132.13 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 3.2% Upside | Upgrade to Pro+ | |
Collegium Pharmaceutical | NASDAQ | Healthcare | Pharmaceuticals | 1.8 | $968.80M | 10.9x | 0.01 | $29.91 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 41.6% Upside | Upgrade to Pro+ | |
HCA | NYSE | Healthcare | Healthcare Providers & Services | 1.8 | $79.62B | 14.5x | 0.87 | $320.56 | 1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 18.5% Upside | Upgrade to Pro+ | |
Supernus | NASDAQ | Healthcare | Pharmaceuticals | 1.8 | $1.84B | 30.9x | 0.28 | $33.52 | -15.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 10.9% Upside | Upgrade to Pro+ | |
LivaNova PLC | NASDAQ | Healthcare | Healthcare Equipment & Supplies | 1.82 | $2.57B | 108.3x | 0.14 | $47.51 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 48.9% Upside | Upgrade to Pro+ | |
Cardinal Health | NYSE | Healthcare | Pharmaceuticals | 1.82 | $30.59B | 23.4x | 0.25 | $126.75 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 14.9% Upside | Upgrade to Pro+ | |
Inspire Medical Systems | NYSE | Healthcare | Healthcare Equipment & Supplies | 1.82 | $5.30B | 99.1x | 0.3 | $178.72 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 29.9% Upside | Upgrade to Pro+ | |
Merck&Co | NYSE | Healthcare | Pharmaceuticals | 1.85 | $216.26B | 12.6x | 0 | $85.60 | 2.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 34.2% Upside | Upgrade to Pro+ | |
Regeneron Pharma | NASDAQ | Healthcare | Biotechnology & Medical Research | 1.89 | $73.33B | 16.7x | 1.59 | $685.66 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 38.3% Upside | Upgrade to Pro+ | |
Alkermes Plc | NASDAQ | Healthcare | Biotechnology & Medical Research | 1.93 | $5.83B | 16.2x | 4.52 | $35.84 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 6.1% Upside | Upgrade to Pro+ | |
GE HealthCare | NASDAQ | Healthcare | Healthcare Equipment & Supplies | 1.95 | $42.17B | 21.3x | 0.49 | $92.52 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 11.1% Upside | Upgrade to Pro+ | |
Avantor | NYSE | Healthcare | Healthcare Equipment & Supplies | 1.95 | $12.05B | 16.7x | 0.14 | $17.68 | 1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 44.1% Upside | Upgrade to Pro+ | |
Intuitive Surgical | NASDAQ | Healthcare | Healthcare Equipment & Supplies | 1.97 | $217.16B | 93x | 3.31 | $608.48 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 7.1% Upside | Upgrade to Pro+ | |
Essilor International SA | OTC Markets | Healthcare | Healthcare Equipment & Supplies | 2 | $139.37B | 56.3x | 57.93 | $153.11 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -21.1% Downside | Upgrade to Pro+ | |
Cooper | NASDAQ | Healthcare | Healthcare Equipment & Supplies | 2 | $17.24B | 44.1x | 1.38 | $86.46 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 31.7% Upside | Upgrade to Pro+ | |
Haemonetics | NYSE | Healthcare | Healthcare Equipment & Supplies | 2 | $3.21B | 25.1x | 7.53 | $63.66 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ConvaTec ADR | OTC Markets | Healthcare | Healthcare Equipment & Supplies | 2 | $6.30B | 41x | 0.35 | $12.45 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 10.1% Upside | Upgrade to Pro+ | |
Select Medical | NYSE | Healthcare | Healthcare Providers & Services | 2 | $2.49B | 9.1x | 0.42 | $19.25 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 31.1% Upside | Upgrade to Pro+ | |
Smith&Nephew SNATS | NYSE | Healthcare | Healthcare Equipment & Supplies | 2 | $11.19B | 36.8x | 0.93 | $25.62 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 19.6% Upside | Upgrade to Pro+ | |
Kiora Pharmaceuticals | NASDAQ | Healthcare | Biotechnology & Medical Research | 2 | $10.65M | 2x | 0.02 | $3.51 | -5.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Aurora Cannabis | NASDAQ | Healthcare | Pharmaceuticals | 2 | $318.27M | 88.4x | 0.27 | $5.79 | -4.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
UFP | NASDAQ | Healthcare | Healthcare Equipment & Supplies | 2 | $2.01B | 36.7x | 1.25 | $260.35 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 49.7% Upside | Upgrade to Pro+ |